USPTO trademark

ALLYNZA STUDY CELL-BASED ADJUVANT TECHNOLOGY

Under examinationUSPTOWord and designClass 42Class 44

"ALLYNZA STUDY CELL-BASED ADJUVANT TECHNOLOGY" is a word and design mark owned by Seqirus Inc., filed at the USPTO on March 2, 2026. It is under examination and covers classes 42 and 44.

View Seqirus Inc. portfolioGet this data via the API
Official USPTO record
ALLYNZA STUDY CELL-BASED ADJUVANT TECHNOLOGY trademark as filed
As filed with the USPTO
Status
Under examination
Since May 26, 2026
Filed
March 2, 2026
Registered
Not yet
Expires
Not recorded
Application no.
99677818
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word and design
2 classes
Ownership

Who owns ALLYNZA STUDY CELL-BASED ADJUVANT TECHNOLOGY

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Seqirus Inc.

Holly Springs, United States

231 trademarks in the portfolioView company

Representative

Nancy Sabarra

Fross Zelnick Lehrman & Zissu, P.C.

Goods and services

What the mark covers

The products and services ALLYNZA STUDY CELL-BASED ADJUVANT TECHNOLOGY is filed for, grouped by Nice class.

  • Providing clinical trial research information about the results of clinical trials for flu vaccines; providing medical research and scientific research information in the field of flu vaccines and flu vaccine clinical trials; pharmaceutical research and development; Providing information about pharmaceutical research and development

  • Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; and medical information

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Application extension granted/receipt provided
  2. Application extension to response period - received
  3. Notification of non-final action e-mailed
  4. Non-final action e-mailed
  5. Non-final action written
  6. Assigned to examiner
  7. Notice of design search code e-mailed
  8. New application office supplied data entered
  9. Application filing receipt mailed
  10. New application entered
FAQ

About ALLYNZA STUDY CELL-BASED ADJUVANT TECHNOLOGY

Who owns the trademark "ALLYNZA STUDY CELL-BASED ADJUVANT TECHNOLOGY"?

The USPTO trademark "ALLYNZA STUDY CELL-BASED ADJUVANT TECHNOLOGY" (application 99677818) is owned by Seqirus Inc.

What is the status of "ALLYNZA STUDY CELL-BASED ADJUVANT TECHNOLOGY"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull ALLYNZA STUDY CELL-BASED ADJUVANT TECHNOLOGY and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2bb1-86bc-73dd-9fa1-ea9b234a9baf
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2bb1-86bc-73dd-9fa1-ea9b234a9baf",
  "object": "trademark",
  "mark_text": "ALLYNZA STUDY CELL-BASED ADJUVANT TECHNOLOGY",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "99677818",
  "filing_date": "2026-03-02",
  "nice_classes": [
    42,
    44
  ],
  "owners": [
    {
      "name": "Seqirus Inc.",
      "entity_id": "ent_019eb7d7-073e-746b-967e-2a965cfa764c"
    }
  ]
}